Table 3. Diagnostic value of CEA and KRAS to differentiate mucinous vs. non-mucinous cysts.
All patients n = 943 | Surgical cohort n = 147 | Clinical cohort n = 796 | |||||||
Test | KRAS+ | CEA↑ | KRAS+ or CEA↑ | KRAS+ | CEA↑ | KRAS+ or CEA↑ | KRAS+ | CEA↑ | KRAS+ or CEA↑ |
Sensitivity % | 48.3 | 56.3 | 75.8 | 46.3 | 63.2 | 77 | 48.8 | 54.6 | 75.6 |
Specificity % | 100 | 93.2 | 93.2 | 100 | 90.9 | 91.1 | 100 | 93.8 | 93.8 |
PPV % | 100 | 95.4 | 96.6 | 100 | 94.8 | 95.7 | 100 | 95.6 | 96.8 |
NPV % | 47 | 45.9 | 60.6 | 40.2 | 48.3 | 60.7 | 48.2 | 45.2 | 60.5 |
Accuracy % | 64.5 | 66.8 | 80.9* | 60.5 | 70.8 | 81.6^ | 65.3 | 65.8 | 80.81 |
AUC | 0.742 | 0.748 | 0.846* | 0.730 | 0.781 | 0.838~ | 0.744 | 0.742 | 0.8471 |
Abbreviation: PPV, positive predictive value; NPV, negative predictive value; AUC, area under curve
P < 0.0001 vs. KRAS + and CEA↑ alone, ^P < 0.01 vs KRAS + , > 0.05 vs CEA↑ alone,~ P > 0.05 vs. KRAS + and CEA↑ alone